1.

Record Nr.

UNINA9910767585903321

Autore

Gupta Shikha

Titolo

Childhood Glaucoma : A Case Based Color and Video Atlas

Pubbl/distr/stampa

Singapore : , : Springer, , 2024

©2023

ISBN

981-19-7466-7

Edizione

[1st ed.]

Descrizione fisica

1 online resource (412 pages)

Altri autori (Persone)

MahalingamKarthikeyan

GuptaViney

Disciplina

618.9209774100223

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Nota di contenuto

Intro -- Contents -- About the Editors and Contributors -- About the Editors -- Contributors -- Part I: The Genesis of Childhood Glaucoma -- 1: Embryology and Pathophysiology of Childhood Glaucoma -- 1.1  Embryology -- 1.2  Pathophysiology of Childhood Glaucoma -- 1.2.1  Angular Neurocristopathies -- 1.3 Conclusions -- Suggested Reading -- 2: Classification of Childhood Glaucoma -- 2.1  Classification of Childhood Glaucomas -- 2.1.1  Based on Age of Onset -- 2.1.2  Based on Developmental Pattern -- 2.1.3  Based on Anatomy -- 2.1.4  Syndrome Classification of Congenital Glaucoma (Shaffer-Weiss, Table 2.1) -- 2.1.5  Childhood Glaucoma Research Network Classification -- 2.1.5.1  Primary Childhood Glaucoma -- Primary Congenital Glaucoma (PCG) -- Juvenile Open-Angle Glaucoma (JOAG) -- 2.1.5.2  Secondary Childhood Glaucoma -- A. Glaucoma Associated with Non-acquired Ocular Anomalies -- B. Glaucoma Associated with Non-acquired Systemic Disease or Syndrome -- C. Glaucoma Associated with Acquired Condition -- D. Glaucoma Following Cataract Surgery -- 2.2 Conclusions -- Suggested Reading -- 3: The Role of Genetic Testing in Childhood Glaucoma -- 3.1  Selected Genetics of Childhood Glaucomas -- 3.1.1  Primary Congenital Glaucoma (PCG) -- 3.1.2  Juvenile Open-Angle Glaucoma (JOAG) -- 3.1.3  Axenfeld-Rieger Syndrome (ARS) -- 3.1.4  Classic Aniridia (AN) -- 3.1.5  Peters Anomaly -- 3.2  The Role of Genetic Testing in Childhood Glaucoma --



3.2.1  Scenario 1: Genetic Counseling Is Desired and Is Reasonable -- 3.2.2  Scenario 2: Clinical Exam Suggests a Potential Risk for Actionable Extraocular Disease -- 3.2.3  Scenario 3: The Glaucoma Is in the Setting of and Related to Systemic Disease -- 3.2.4  Scenario 4: The Diagnosis Is Questionable (Certain Populations) -- 3.3 Conclusions -- Suggested Reading -- Part II: Clinical Evaluation -- 4: Tonometry.

4.1  Natural Sleep/Sleep Under Sedatives -- 4.2  General Anesthesia (Fig. 4.3) -- 4.3  Methods of Tonometry (Tables 4.1, 4.2) -- 4.3.1  Goldmann Applanation Tonometer -- 4.3.1.1  Principle -- 4.3.1.2  Procedure (Video 4.1) -- 4.3.1.3  Disinfection of the Prism -- 4.3.1.4  Sources of Errors -- 4.3.2  Perkins -- 4.3.2.1  Principle -- 4.3.2.2  Procedure (Video 4.2) -- 4.3.2.3  Calibration (Video 4.3) -- 4.3.3  Tonopen -- 4.3.3.1  Principle -- 4.3.3.2  Procedure (Video 4.4) -- 4.3.3.3  Calibration -- 4.3.4  Rebound Tonometer -- 4.3.4.1  Principle -- 4.3.4.2  Procedure (Video 4.5) -- 4.3.4.3  Calibration -- 4.3.5  Noncontact Tonometer -- 4.3.5.1  Principle -- 4.3.5.2  Calibration -- 4.3.5.3  Procedure (Video 4.6) -- 4.3.6  Transpalpebral Tonometer -- 4.3.6.1  Principle -- 4.3.6.2  Procedure -- 4.3.7  Dynamic Contour Tonometer (DCT) -- 4.3.7.1  Principle -- 4.3.7.2  Procedure -- 4.3.8  Digital Tonometry (Palpation) -- 4.3.8.1  Procedure (Video 4.7) -- 4.4  Conclusions -- Suggested Reading -- 5: Childhood Glaucoma: Gonioscopy -- 5.1  Direct Gonioscopy -- 5.1.1  Principle of Direct Gonioscopy -- 5.1.2  Lenses -- 5.1.3  Procedure of Direct Gonioscopy (Video 5.1) -- 5.2  Indirect Gonioscopy -- 5.2.1  Principle -- 5.2.2  Lenses -- 5.2.3  Procedure of Indirect Gonioscopy (Video 5.2) -- 5.3  Case-Based Examples -- 5.4 Conclusions -- Suggested Reading -- 6: Fundus Evaluation in Childhood Glaucoma -- 6.1  Case Examples -- 6.2 Conclusions -- Suggested Reading -- 7: Pediatric Perimetry -- 7.1  Introduction -- 7.1.1  Perimetry in Children -- 7.2  Case Examples -- 7.3  Progression on HFA -- 7.3.1  Visual Field Index Analysis -- 7.4  Progression on MRF -- 7.5  Prospects -- 7.6 Conclusions -- Suggested Reading -- 8: Examination Under Anesthesia -- 8.1  Introduction -- 8.2  Pre-procedure Concerns -- 8.3  Intraoperative Management.

8.4  Order of Examination During EUA (Table 8.3) -- 8.5  Post-operative Management -- 8.6  Follow-Up -- 8.7  Case Scenarios -- 8.8  Conclusions -- Suggested Reading -- Part III: Primary Childhood Glaucoma -- 9: Primary Congenital Glaucoma -- 9.1  Case Examples -- 9.2  Management of PCG (Fig. 9.12) -- 9.3 Conclusions -- Suggested Reading -- 10: Juvenile Onset Open-Angle Glaucoma -- 10.1  Case Examples -- 10.2  Management Strategies (Fig. 10.17) -- 10.3 Conclusions -- Suggested Reading -- Part IV: Secondary Childhood Glaucoma with Non Acquired Conditions -- 11: Axenfeld-Rieger Syndrome -- 11.1  Case Examples -- 11.2  Management Protocol -- 11.3  Conclusions -- Suggested Reading -- 12: Peters Anomaly with Glaucoma -- 12.1  Introduction -- 12.2  Genetics -- 12.3  Pathophysiology of Peters Anomaly and Associated Glaucoma -- 12.4  Clinical Picture -- 12.5  Types of Peters Anomaly -- 12.6  Differential Diagnosis -- 12.7  Evaluation of Patient with Peters Anomaly -- 12.8  Management of Glaucoma in Peters Anomaly -- 12.9 Conclusions -- Suggested Reading -- 13: Congenital Ectropion Uveae with Glaucoma -- 13.1  Introduction -- 13.2  Etiopathogenesis -- 13.3  Case Examples -- 13.4 Conclusions -- Suggested Reading -- 14: Aniridia with Glaucoma -- 14.1  Introduction -- 14.2  Clinical Features -- 14.3  Pathophysiology of Glaucoma in Aniridia: Fig. 14.1 (Table 14.1) -- 14.3.1  Differential Diagnosis -- 14.4  Case Examples -- 14.5  Conclusions -- Suggested Reading -- 15: Lens-Associated Glaucomas -- 15.1 Introduction -- 15.2 Pathophysiology -- 15.3  Management Algorithm for Phacotopic Glaucomas (Fig. 15.10) -- 15.4 Conclusions



-- Suggested Reading -- 16: Sturge-Weber Syndrome and Associated Syndromes with Glaucoma -- 16.1  Sturge-Weber Syndrome -- 16.1.1  Background -- 16.1.2  Pathogenesis -- 16.2  Klippel-Trenaunay-Weber Syndrome -- 16.2.1  Ocular Signs.

16.2.2  Systemic Signs -- 16.2.3  Differential Diagnosis -- 16.2.4  Management -- 16.3  Phakomatosis Pigmentovascularis -- 16.3.1  Pathogenesis -- 16.3.2  Clinical Features -- 16.3.2.1  Dermatological Features -- 16.3.2.2  Ocular Features -- 16.3.2.3  Neurologic Abnormalities -- 16.3.2.4  Syndromic Associations -- 16.3.3  Management -- 16.4  Conclusions -- Suggested Reading -- 17: Miscellaneous Secondary Childhood Glaucomas -- 17.1  Congenital Rubella Syndrome -- 17.1.1  Background -- 17.1.2  Pathogenesis -- 17.1.3  Clinical Features -- 17.1.3.1  Systemic Features -- 17.1.3.2  Ocular Features: -- 17.1.4  Investigations -- 17.1.5  Management -- 17.2  Persistent Fetal Vasculature (PFV) -- 17.2.1  Background -- 17.2.2  Clinical Features -- 17.2.2.1  Ocular Manifestations -- 17.2.3  Investigations -- 17.2.4  Pathogenesis and Treatment of Glaucoma Secondary to Persistent Fetal Vasculature -- 17.3  Keratomalacia -- 17.3.1  Background -- 17.3.2  Pathogenesis -- 17.3.3  Systemic Features -- 17.3.4  Differential Diagnoses -- 17.3.5  Management -- 17.3.6  Therapy -- 17.4  Nevus of Ota -- 17.4.1  Background -- 17.4.2  Differential Diagnoses -- 17.4.3  Pathogenesis and Treatment of Glaucoma in Oculodermal Melanocytosis (Fig. 17.18) -- 17.4.4  Management -- 17.5  Microphthalmos -- 17.5.1  Background -- 17.5.2  Types of Microphthalmos -- 17.5.3  Differential Diagnosis -- 17.5.4  Clinical Features -- 17.5.5  Investigations -- 17.5.5.1  Electroretinogram -- 17.5.5.2  OCT -- 17.5.5.3  Diagnosis of Glaucoma -- 17.5.6  Pathogenesis of Glaucoma -- 17.5.7  Management of Glaucoma Secondary to Microphthalmos -- 17.6 Conclusions -- Suggested Reading -- Part V: Acquired Secondary Childhood Glaucoma -- 18: Postsurgical Glaucoma -- 18.1  Glaucoma Following Cataract Surgery -- 18.1.1  Introduction -- 18.1.2  Mechanisms.

18.1.3  Risk Factors for Progression into Secondary Glaucoma in Eyes Undergoing Pediatric Cataract Surgery -- 18.2  Glaucoma Following Vitreoretinal Surgeries -- 18.2.1  Mechanism of Angle-Closure Post buckle Surgery -- 18.2.2  Intravitreal Tamponade Agents -- 18.2.3  Management of Glaucoma After Scleral Buckling -- 18.2.4  Management of Glaucoma Post-vitrectomy Surgery -- 18.3  Glaucoma Post-penetrating Keratoplasty -- 18.4  Management Algorithm (Fig. 18.9) -- 18.5 Conclusions -- Suggested Reading -- 19: Uveitic Glaucoma -- 19.1  Etiology of Uveitis -- 19.2  Prevalence of Glaucoma in Uveitis -- 19.2.1 Hypotony: -- 19.3  Pathophysiology of Uveitic Glaucoma -- 19.3.1  Open-Angle Mechanisms: -- 19.3.2  Angle-Closure Mechanisms: -- 19.4  Clinical Examples -- 19.5  Management of Glaucoma -- 19.6 Conclusions -- Suggested Reading -- 20: Post-Traumatic Glaucoma -- 20.1  Case Examples -- 20.2  Management Strategies (Figs. 20.19 and 20.20) -- 20.3 Conclusions -- Suggested Reading -- 21: Glaucoma in Retinopathy of Prematurity -- 21.1  Introduction -- 21.2  Glaucoma in ROP -- 21.3  Etiopathogenesis of Glaucoma in ROP -- 21.4  Management of Glaucoma in ROP Eyes -- 21.5  Case Examples -- 21.6 Conclusions -- Suggested Reading -- 22: Steroid-Induced Glaucoma -- 22.1  Introduction -- 22.2  Mechanisms of Corticosteroid-Induced Increase in IOP -- 22.3  Risk Factors -- 22.4  Case Examples -- 22.5  Management -- 22.6 Conclusions -- Suggested Reading -- 23: Retinoblastoma with Glaucoma -- 23.1  Pathophysiology -- 23.2  Case Examples -- 23.3   Conclusions -- Suggested Reading -- Part VI: Ancillary Investigations -- 24: Anterior



Segment Imaging in Childhood Glaucoma -- 24.1  Introduction -- 24.2  Ultrasound Biomicroscopy -- 24.2.1  Procedure for UBM (VuMAX, Sonomed Escalon, New York) -- 24.3  Anterior Chamber Optical Coherence Tomography ( ASOCT).

24.4  Uses of Anterior Segment Imaging in Glaucoma.